{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:17:38Z","timestamp":1720138658424},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,4]]},"DOI":"10.7759\/cureus.63810","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T10:54:02Z","timestamp":1720090442000},"source":"Crossref","is-referenced-by-count":0,"title":["Importance of Vaccination Against COVID-19 in a Patient With End-Stage Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)"],"prefix":"10.7759","author":[{"given":"Bella","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirmohsen","family":"Arbabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnell A","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paryus","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/pl00006853","article-title":"Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis","volume":"19","author":"Cimmino MA","year":"2000","unstructured":"Cimmino MA, Salvarani C, Macchioni P, et al.. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int. 2000, 19:213-7. 10.1007\/pl00006853","journal-title":"Rheumatol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.12.004","article-title":"Lung disease in rheumatoid arthritis","volume":"41","author":"Yunt ZX","year":"2015","unstructured":"Yunt ZX, Solomon JJ. Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2015, 41:225-36. 10.1016\/j.rdc.2014.12.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00256-9","article-title":"Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease","volume":"4","author":"Kelly C","year":"2022","unstructured":"Kelly C. Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease. Lancet Rheumatol. 2022, 4:e741-3. 10.1016\/S2665-9913(22)00256-9","journal-title":"Lancet Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1908887","article-title":"Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic","volume":"17","author":"Favalli EG","year":"2021","unstructured":"Favalli EG, Maioli G, Biggioggero M, Caporali R. Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Rev Clin Immunol. 2021, 17:561-71. 10.1080\/1744666X.2021.1908887","journal-title":"Expert Rev Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000930","article-title":"Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic","volume":"35","author":"Zaccardelli A","year":"2023","unstructured":"Zaccardelli A, Wallace ZS, Sparks JA. Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic. Curr Opin Rheumatol. 2023, 35:175-84. 10.1097\/BOR.0000000000000930","journal-title":"Curr Opin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1288","article-title":"COVID-19 infection and clinical outcomes in hospitalized patients with rheumatoid arthritis: insights from the National Inpatient Sample","volume":"14","author":"Davis MG","year":"2024","unstructured":"Davis MG, Akhlaq A, Aamer S, Shuja H, Edigin E, Sheikh AB. COVID-19 infection and clinical outcomes in hospitalized patients with rheumatoid arthritis: insights from the National Inpatient Sample. J Community Hosp Intern Med Perspect. 2024, 14:5-12. 10.55729\/2000-9666.1288","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S411299","article-title":"Clinical characteristics and outcomes of vaccinated vs non-vaccinated critically ill COVID-19 patients: retrospective observation study","volume":"16","author":"AlQahtani SY","year":"2023","unstructured":"AlQahtani SY, Alabdulqader AA, Al Mashhour WA, et al.. Clinical characteristics and outcomes of vaccinated vs non-vaccinated critically ill COVID-19 patients: retrospective observation study. Infect Drug Resist. 2023, 16:3329-38. 10.2147\/IDR.S411299","journal-title":"Infect Drug Resist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01257-7","article-title":"Estimation of the effect of vaccination in critically ill COVID-19 patients, analysis using propensity score matching","volume":"14","author":"Havaldar AA","year":"2024","unstructured":"Havaldar AA, Selvam S. Estimation of the effect of vaccination in critically ill COVID-19 patients, analysis using propensity score matching. Ann Intensive Care. 2024, 14:24. 10.1186\/s13613-024-01257-7","journal-title":"Ann Intensive Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.35219","article-title":"Association between vaccination status and mortality among intubated patients with COVID-19-related acute respiratory distress syndrome","volume":"5","author":"Grapsa E","year":"2022","unstructured":"Grapsa E, Adamos G, Andrianopoulos I, et al.. Association between vaccination status and mortality among intubated patients with COVID-19-related acute respiratory distress syndrome. JAMA Netw Open. 2022, 5:e2235219. 10.1001\/jamanetworkopen.2022.35219","journal-title":"JAMA Netw Open"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123291","article-title":"COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges","volume":"10","author":"Dewanjee S","year":"2021","unstructured":"Dewanjee S, Kandimalla R, Kalra RS, et al.. COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges. Cells. 2021, 10:3291. 10.3390\/cells10123291","journal-title":"Cells"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama S","year":"2021","unstructured":"Akiyama S, Hamdeh S, Micic D, Sakuraba A. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021, 80:384-91.","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04857-9","article-title":"Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases","volume":"41","author":"Alzahrani ZA","year":"2021","unstructured":"Alzahrani ZA, Alghamdi KA, Almaqati AS. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases. Rheumatol Int. 2021, 41:1097-103. 10.1007\/s00296-021-04857-9","journal-title":"Rheumatol Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00562-2","article-title":"Rheumatic disease and COVID-19: epidemiology and outcomes","volume":"17","author":"Hyrich KL","year":"2021","unstructured":"Hyrich KL, Machado PM. Rheumatic disease and COVID-19: epidemiology and outcomes. Nat Rev Rheumatol. 2021, 17:71-2. 10.1038\/s41584-020-00562-2","journal-title":"Nat Rev Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1977-9","article-title":"Respiratory viral infections and the risk of rheumatoid arthritis","volume":"21","author":"Joo YB","year":"2019","unstructured":"Joo YB, Lim YH, Kim KJ, Park KS, Park YJ. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019, 21:199. 10.1186\/s13075-019-1977-9","journal-title":"Arthritis Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.939870","article-title":"Inflammatory arthritis after COVID-19: a case series","volume":"24","author":"Yadav S","year":"2023","unstructured":"Yadav S, Bonnes SL, Gilman EA, Mueller MR, Collins NM, Hurt RT, Ganesh R. Inflammatory arthritis after COVID-19: a case series. Am J Case Rep. 2023, 24:e939870. 10.12659\/AJCR.939870","journal-title":"Am J Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-219859","article-title":"Onset of rheumatoid arthritis after COVID-19: coincidence or connected?","volume":"80","author":"Derksen VF","year":"2021","unstructured":"Derksen VF, Kissel T, Lamers-Karnebeek FB, et al.. Onset of rheumatoid arthritis after COVID-19: coincidence or connected?. Ann Rheum Dis. 2021, 80:1096-8. 10.1136\/annrheumdis-2021-219859","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco M","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, et al.. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020, 79:859-66. 10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41533-022-00300-z","article-title":"The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19","volume":"32","author":"Kushner P","year":"2022","unstructured":"Kushner P, McCarberg BH, Grange L, et al.. The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19. NPJ Prim Care Respir Med. 2022, 32:35. 10.1038\/s41533-022-00300-z","journal-title":"NPJ Prim Care Respir Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2022_068","article-title":"Risk factors and the impact of vaccination on mortality in COVID-19 patients","volume":"123","author":"Sezen YI","year":"2022","unstructured":"Sezen YI, Senoglu S, Karabela SN, et al.. Risk factors and the impact of vaccination on mortality in COVID-19 patients. Bratisl Lek Listy. 2022, 123:440-3. 10.4149\/BLL_2022_068","journal-title":"Bratisl Lek Listy"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2024.45.2.20230530","article-title":"Impact of vaccination on morbidity and mortality in adults hospitalized with COVID-19 during the omicron wave in the Jazan Region, Saudi Arabia","volume":"45","author":"Elamin MY","year":"2024","unstructured":"Elamin MY, Maslamani YA, Alsheikh FA, et al.. Impact of vaccination on morbidity and mortality in adults hospitalized with COVID-19 during the omicron wave in the Jazan Region, Saudi Arabia. Saudi Med J. 2024, 45:179-87. 10.15537\/smj.2024.45.2.20230530","journal-title":"Saudi Med J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1151311","article-title":"Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries","volume":"14","author":"Matveeva O","year":"2023","unstructured":"Matveeva O, Shabalina SA. Comparison of vaccination and booster rates and their impact on excess mortality during the COVID-19 pandemic in European countries. Front Immunol. 2023, 14:1151311. 10.3389\/fimmu.2023.1151311","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14049","article-title":"Effect of comorbid pulmonary disease on the severity of COVID\u201019: a systematic review and meta\u2010analysis","volume":"26","author":"G\u00fclsen A","year":"2021","unstructured":"G\u00fclsen A, K\u00f6nig IR, Jappe U, Dr\u00f6mann D. Effect of comorbid pulmonary disease on the severity of COVID\u201019: a systematic review and meta\u2010analysis. Respirology. 2021, 26:552-65. 10.1111\/resp.14049","journal-title":"Respirology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study","volume":"202","author":"Drake TM","year":"2020","unstructured":"Drake TM, Docherty AB, Harrison EM, et al.. Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study. Am J Respir Crit Care Med. 2020, 202:1656-65. 10.1164\/rccm.202007-2794OC","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269900-importance-of-vaccination-against-covid-19-in-a-patient-with-end-stage-rheumatoid-arthritis-associated-interstitial-lung-disease-ra-ild","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T10:54:05Z","timestamp":1720090445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269900-importance-of-vaccination-against-covid-19-in-a-patient-with-end-stage-rheumatoid-arthritis-associated-interstitial-lung-disease-ra-ild"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.63810","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,4]]}}}